Kspine is focused on developing and marketing innovative solutions to correct scoliosis deformity for pediatric patients, while striving to minimize impact to the spine, preserve mobility and maximize quality of life. The company has a CE Mark on its first product designed to treat adolescent scoliosis (10-18 year olds) and is conducting a post-market clinical trial in Europe. A European launch is planned for mid-2015. Kspine is a privately held, venture-capital financed company based in Minnetonka, MN.